Development of ketoprofen loaded proliposomal powders for improved gastric absorption and gastric tolerance: in vitro and in situ evaluation

References

• Burcham DL, Maurin MB, Hausner EA, Huang SM. Improved oral bioavailability of the hypocholestrolemic DMP 565 in dogs following oral dosing in oil and glycol solutions. Biopharm Drug Dispos 1997;18:737–742
   PubMed Web of Science ®Google Scholar
• Sentjurc M, Vrhovnik K, Kristl J. Liposomes as a topical delivery system: the role of size on transport studies by the EPR imaging method. J Control Release 1999;59:87–97
   PubMed Web of Science ®Google Scholar
• Henry D, Lim LL, Garcia Rodriguez LA, et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of collaborative meta-analysis. BMJ 1996;312:1563–1566
   PubMed Web of Science ®Google Scholar
• Topaloglu Y, Yener G, Gonullu U. Inclusion of ketoprofen with skimmed milk by freeze-drying. Farmaco 1999;54:648–652
   PubMedGoogle Scholar
• Tayade PT, Vavia PR. Inclusion complexes of ketoprofen with β-cyclodextrins: oral pharmacokinetics of ketoprofen in human. Indian J Pharm Sci 2006;68:164–170
   Google Scholar
• Comoglu T, Savaser A, Ozkan Y, et al. Enhancement of ketoprofen bioavailability by formation of microsponge tablets. Pharmazie 2007;62:51–54
   PubMed Web of Science ®Google Scholar
• de Villiers MM, Liebenberg W, Malan SF, Gerber JJ. The dissolution and complexing properties of ibuprofen and ketoprofen when mixed with N-methylglucamine. Drug Dev Ind Pharm 1999;25:967–972
   PubMed Web of Science ®Google Scholar
• Cirri M, Maestrelli F, Mennini N, Mura P. Influence of the preparation method on the physical-chemical properties of ketoprofen-cyclodextrin-phosphatidylcholine ternary systems. J Pharm Biomed Anal 2009;50:690–694
   PubMed Web of Science ®Google Scholar
• Imran ul-haq M, Chasovskikh E, Signorell R. Phase behavior of ketoprofen- poly(lactic acid) drug particles formed by rapid expansion of supercritical solutions. Langmuir 2010;26:14951–14957
   PubMedGoogle Scholar
• Charman WN, Porter CJ, Mithani S, Dressman JB. Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. J Pharm Sci 1997;86:269–282
   PubMed Web of Science ®Google Scholar
• Sunesen VH, Vedelsdal R, Kristensen HG, et al. Effect of liquid volume and food intake on the absolute bioavailability of danazol, a poorly soluble drug. Eur J Pharm Sci 2005;24:297–303
   PubMed Web of Science ®Google Scholar
• Pouton CW. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci 2006;29:278–287
   PubMed Web of Science ®Google Scholar
• Porter CJ, Trevaskis NL, Charman WN. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov 2007;6:231–248
   PubMed Web of Science ®Google Scholar
• Fukunaga M, Miller MM, Deftos LJ. Liposome-entrapped calcitonin and parathyroid hormone are orally effective in rats. Horm Metab Res 1991;23:166–167
   PubMedGoogle Scholar
• Ariën A, Goigoux C, Baquey C, Dupuy B. Study of in vitro and in vivo stability of liposomes loaded with calcitonin or indium in the gastrointestinal tract. Life Sci 1993;53:1279–1290
   PubMed Web of Science ®Google Scholar
• Grit M, Desmidt JH, Struijke A, Crommelin DJA. Hydrolysis of phosphatidylcholine in aqueous liposome dispersions. Int J Pharm 1989;50:1–6
   Web of Science ®Google Scholar
• Hunt CA, Tsang S. α-Tocopherol retards autoxidation and prolongs the shelf life of liposomes. Int J Pharm 1981;8:101–110
   Web of Science ®Google Scholar
• Payne NI, Timmins P, Ambrose CV, et al. Proliposomes: a novel solution to an old problem. J Pharm Sci 1986;75:325–329
   PubMed Web of Science ®Google Scholar
• Aburahma MH, Abdelbary GA. Novel diphenyl dimethyl bicarboxylate provesicular powders with enhanced hepatocurative activity: preparation, optimization, in vitro/in vivo evaluation. Int J Pharm 2012;422:139–150
   PubMed Web of Science ®Google Scholar
• Hiremath PS, Soppimath KS, Betageri GV. Proliposomes of exemestane for improved oral delivery: formulation and in vitro evaluation using PAMPA, Caco-2 and rat intestine. Int J Pharm 2009;380:96–104
   PubMed Web of Science ®Google Scholar
• Katare OP, Vyas SP, Dixit VK. Proliposomes of indomethacin for oral administration. J Microencapsul 1991;8:1–7
   PubMed Web of Science ®Google Scholar
• Song KH, Chung SJ, Shim CK. Preparation and evaluation of proliposomes containing salmon calcitonin. J Control Release 2002;84:27–37
   PubMed Web of Science ®Google Scholar
• Yan-yu X, Yun-mei S, Zhi-peng C, Qi-neng P. Preparation of silymarin proliposome: a new way to increase oral bioavailability of silymarin in beagle dogs. Int J Pharm 2006;319:162–168
   PubMed Web of Science ®Google Scholar
• Carr RL. Evaluating flow properties of solids. Chem Eng 1965;72:163–168
   Google Scholar
• Jukanti R, Sheela S, Bandari S, Veerareddy PR. Enhanced bioavailability of exemestane via proliposomes based transdermal delivery. J Pharm Sci 2011;100:3208–3222
   PubMed Web of Science ®Google Scholar
• Elhissi AMA, Ahmed W, McCarthy D, Taylor KMG. A study of size, microscopic morphology and dispersion mechanism of structures generated on hydration of proliposomes. J Dispersion Sci Technol 2012;33:1121–1126
   Web of Science ®Google Scholar
• Khan KA. The concept of dissolution efficiency. J Pharm Pharmacol 1975;27:48–49
   PubMed Web of Science ®Google Scholar
• Eedara BB, Veerareddy PR, Jukanti R, Bandari S. Improved oral bioavailability of fexofenadine hydrochloride using lipid surfactants: ex vivo, in situ and in vivo studies. Drug Dev Ind Pharm 2013; Early online 1–14 . [Epub ahead of print]. doi: 10.3109/03639045.2013.801984
   Google Scholar
• Li H, Zhao X, Ma Y, et al. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J Control Release 2009;133:238–244
   PubMed Web of Science ®Google Scholar
• Yin LF, Huang SJ, Zhu CL, et al. In vitro and in vivo studies on a novel solid dispersion of repaglinide using polyvinylpyrrolidone as the carrier. Drug Dev Ind Pharm 2012;38:1371–1380
   PubMed Web of Science ®Google Scholar
• Janga KY, Jukanti R, Velpula A, et al. Bioavailability enhancement of zaleplon via proliposomes: role of surface charge. Eur J Pharm Biopharm 2012;80:347–357
   PubMed Web of Science ®Google Scholar
• Ogiso T, Niinaka N, Iwaki M. Mechanism for enhancement effect of lipid disperse system on percutaneous absorption. J Pharm Sci 1996;85:57–64
   PubMed Web of Science ®Google Scholar
• Velpula A, Jukanti R, Janga KY, et al. Proliposome powders for enhanced intestinal absorption and bioavailability of raloxifene hydrochloride: effect of surface charge. Drug Dev Ind Pharm 2013;39:1895–1906
   PubMed Web of Science ®Google Scholar
• Kulkarni SB, Betageri GV, Singh M. Factors affecting microencapsulation of drugs in liposomes. J Microencapsul 1995;12:229–246
   PubMed Web of Science ®Google Scholar
• Abdelbary G. Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes. Pharm Dev Technol 2011;16:44–56
   PubMed Web of Science ®Google Scholar
• Zidan AS, Mokhtar M. Multivariate optimization of formulation variables influencing flurbiprofen proniosomes characteristics. J Pharm Sci 2011;100:2212–2221
   PubMed Web of Science ®Google Scholar
• Moribe K, Maruyama K, Iwatsuru M. Encapsulation characteristics of nystatin in liposomes: effects of cholesterol and polyethylene glycol derivatives. Int J Pharm 1999;188:193–202
   PubMed Web of Science ®Google Scholar
• Aramaki Y, Tomizawa H, Hara T, et al. Stability of liposomes in vitro and their uptake by rat Peyer's patches following oral administration. Pharm Res 1993;10:1228–1231
   PubMed Web of Science ®Google Scholar
• Hancock BC, Zografi G. Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci 1997;86:1–12
   PubMed Web of Science ®Google Scholar
• Nasr M, Mansour S, Mortada ND, Elshamy AA. Vesicular aceclofenac systems: a comparative study between liposomes and niosomes. J Microencapsul 2008;25:499–512
   PubMed Web of Science ®Google Scholar
• Andersen JK. Oxidative stress in neurodegeneration: cause or consequence? Nat Med 2004;5:S18–S25
   Google Scholar
• van der Vliet A, Bast A. Role of reactive oxygen species in intestinal diseases. Free Radic Biol Med 1992;12:499–513
   PubMed Web of Science ®Google Scholar
• Minones Jr J, Conde O, Minones J, et al. Amphotericin B–dipalmitoyl phosphatidyl glycerol interactions responsible for the reduced toxicity of liposomal formulations: a monolayer study. Langmuir 2002;18:8601–8608
   Google Scholar
• Oussoren C, Eling WM, Crommelin DJ, et al. The influence of the route of administration and liposome composition on the potential of liposomes to protect tissue against local toxicity of two antitumor drugs. Biochim Biophys Acta 1998;1369:159–172
   PubMed Web of Science ®Google Scholar
• Gharzouli K, Gharzouli A, Amira S, Khennouf S. Protective effect of mannitol, #glucose-fructose-sucrose-maltose |mixture, and natural honey hyperosmolar solutions against ethanol induced gastric mucosal damage in rats. Exp Toxicol Pathol 2001;53:175–180
   PubMed Web of Science ®Google Scholar
• Xia S, Xu S, Zhang X. Optimization in the preparation of coenzyme Q10 nanoliposomes. J Agric Food Chem 2006;54:6358–6366
   PubMed Web of Science ®Google Scholar
• Xu H, He L, Nie S, et al. Optimized preparation of vinpocetine proliposomes by a novel method and in vivo evaluation of its pharmacokinetics in New Zealand rabbits. J Control Release 2009;140:61–68
   PubMed Web of Science ®Google Scholar